Vela Diagnostics offers real-time polymerase chain reaction (qPCR) tests for the detection and/or quantitation of a wide range of viruses and gene mutations. The flexibility of the platform allows for consolidated testing with a range of sample types.
Our integrated qPCR workflow is highly automated, freeing up valuable resources and reducing turn-around time for lab operators. By offering a flexible system that runs multiple tests on the same platform, simultaneoulsy runs up to four tests in parallel, and identifies several targets in the same sample in the same run, laboratory instrumentation complexity is reduced. Additionally, open-channel capability allows adaptation to lab-specific needs.
Several NGS assays are being developed to identify sequence variants of demonstrated importance, including gene mutations relevant to oncology and viral genotypes, using a variety of sample types.
The Vela Diagnostics NGS solution is easy-to-use, from automated template preparation and library construction, to sequencing, data analysis and reporting. The automated solution reduces sample-to-sample variability, minimizes risk of rerun due to user error/inconsistency, and help produce more accurate results. The open platform allows for adaptation to personalized workflows.
Vela Diagnostics offers a broad portfolio of extraction kits for the isolation of DNA and RNA from various sample types. Reagents are optimized for reliable performance in conjunction with the Vela Diagnostics qPCR and NGS test portfolio. Low sample input amounts and the inclusion of an extraction control are features of all Vela Diagnostics extraction kits.